catumaxomab
CAS No: 509077-98-9
Order
254897-50-2
4,4'-(1,4-Phenylenedi-2,1-Ethenedily)Bis[N-(2-Ethyl-6-Methylphenyl)-N-Phenyl-Benzenamine
62269-06-1
Butanamide, 2-[(2-chlorophenyl)hydrazono]-3-oxo-N-phenyl-, (Z)-
50906-95-1
3,6-anhydro-2,4,5-trideoxy-3,5,6-trimethyl-L-arabino-heptaric acid
62269-01-6
Butanamide, 2-[(4-nitrophenyl)hydrazono]-3-oxo-N-phenyl-, (Z)-
62269-21-0
2-Propenenitrile, 3-phenyl-3-[(trimethylsilyl)oxy]-, (Z)-
509076-56-6
Methanesulfonamide,N-[3-(3,5-dichlorophenoxy)-4-pyridinyl]-1,1,1-trifluoro-
62269-09-4
Butanamide, 2-[(2-methoxyphenyl)hydrazono]-3-oxo-N-phenyl-, (Z)-
62268-79-5
1H-Isoindol-1-one,2,3-dihydro-2-(4-methylphenyl)-3-[(4-nitrophenyl)methylene]-
509073-87-4
Pyridine, 2-(1-naphthalenyloxy)-
62269-20-9
3-Penten-2-one, 3-methyl-4-[(trimethylsilyl)oxy]-, (Z)-
62269-24-3
Phosphonic acid, [2-oxo-1-(2-propenyl)heptyl]-, diethyl ester
50907-10-3
Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-,(2,6-dichlorophenyl)methyl ester
62269-37-8
1-Hexen-3-ol, 2-chloro-1-fluoro-1-phenyl-, (Z)-
6226-89-7
1,3,6-Naphthalenetrisulfonic acid,7-hydroxy-8-[[4-(phenylazo)phenyl]azo]-, trisodium salt
509078-50-6
4H-Furo[3,2-c][1]benzopyran-4-one,2-ethoxy-2,3-dihydro-3-(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-
62268-94-4
1H-Isoindol-1-one,3-[bromo(4-nitrophenyl)methylene]-2,3-dihydro-2-(phenylmethyl)-
509077-98-9
catumaxomab
50906-83-7
Cathafoline
62269-12-9
Butanamide, 2-[(2-hydroxyphenyl)hydrazono]-3-oxo-N-phenyl-, (Z)-
62269-15-2
Butanamide, N-(4-methoxyphenyl)-3-oxo-2-(phenylhydrazono)-, (Z)-
62268-77-3
1H-Isoindol-1-one,2,3-dihydro-2-(2-methylphenyl)-3-[(4-nitrophenyl)methylene]-
509077-98-9
catumaxomab,509077-98-9
2025-10-24 Discover catumaxomab (CAS No: 509077-98-9) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.